Related Experiment Video
Updated: Nov 12, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Distinct Characteristics of COVID-19 Infection in Children
Xuejiao Han1, Xuemei Li2, Yinan Xiao3
1Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Insights
Children are susceptible to COVID-19 (coronavirus disease 2019) and often present mild symptoms. This review summarizes COVID-19 in pediatric patients, highlighting the need for better understanding and management strategies.
Area of Science:
- Virology and Epidemiology
- Pediatric Infectious Diseases
Background:
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has significantly impacted global health.
- Pediatric cases of COVID-19 (coronavirus disease 2019) are increasingly recognized, though less studied than adult cases.
- Children infected with SARS-CoV-2 often exhibit milder symptoms or remain asymptomatic, complicating diagnosis and management.
Purpose of the Study:
- To conduct a literature review on pediatric COVID-19 (coronavirus disease 2019) cases.
- To summarize current knowledge on the pathogenesis, epidemiology, and clinical management of COVID-19 in patients under 18 years old.
- To enhance understanding of SARS-CoV-2 infection in the pediatric population.
Main Methods:
- Literature review of studies published in PubMed and medRxiv (preprints).
- Inclusion criteria: Papers published between December 2019 and December 2020.
- Focus on studies reporting confirmed COVID-19 diagnoses in pediatric patients (aged below 18 years).
Main Results:
- Pediatric COVID-19 (coronavirus disease 2019) cases are often linked to household clusters or exposure to endemic areas.
- Common symptoms in children include fever, cough, and fatigue, generally milder than in adults.
- Laboratory and radiological findings in pediatric patients are frequently non-specific.
Conclusions:
- Data on pediatric COVID-19 (coronavirus disease 2019) remains limited compared to adult populations.
- No specific antiviral treatments are currently approved for children, emphasizing the importance of preventive measures.
- Further research is crucial to improve the understanding and clinical management of SARS-CoV-2 in pediatric patients.
Abstract:
SARS-CoV-2, a member of the family coronaviridae, has triggered a lethal pandemic termed coronavirus disease 2019 (COVID-19). Pediatric patients, mainly from families with a cluster of infection or a history of exposure to epidemic areas, get infected via direct contacts or air-borne droplets. Children (aged below 18 years) are susceptible to COVID-19, with an average incubation period of about 6.5 days. Most cases present asymptomatic or common cold symptoms such as fever, cough, and myalgia or fatigue, which is milder than adult patients. Besides, most abnormal laboratory and radiologic findings in children with COVID-19 are non-specific. Since no specific chemotherapeutic agents have been approved for children, timely preventive methods could effectively forestall the transmission of SARS-CoV-2. To date, mostly studied cases have been adults with COVID-19, whereas data on pediatrics patients remain poorly defined. We herein conducted a literature review for papers published in PubMed and medRxiv (preprints) between December 2019 and December 2020 that reported on pediatrics patients (aged below 18 years) with a confirmed COVID-19 diagnosis. In this review, we summarized and discussed the pathogenesis, epidemiology, and clinical management of COVID-19 in pediatrics patients to improve our understanding of this new disease in children.
Related Concept Videos
Stages of Infection
Endocarditis II: Clinical Features of Infective Endocarditis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Myocarditis II: Clinical Features and Diagnostic Tests
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

